Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HVPG-guided versus heart rate-guided propranolol for primary prevention of esophageal variceal bleeding
NL-OMON55566Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of propranolol in Cirrhosis (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: First variceal bleeding episodes within 2 years. Started Apr 2013; status: active, not recruiting.
02
Drugs
propranolol
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NL-OMON55566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55566.